Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
neuroblastoma
Biotech
Athenex's cash dries up as it faces clinical hold, creditors
After a pediatric patient death, the FDA has slapped a clinical hold on Athenex's phase 1 trial assessing a CAR-NKT cell therapy for neuroblastoma.
Gabrielle Masson
Mar 20, 2023 12:00pm
Y-mAbs' rare disease drug roundly rejected by FDA AdComm
Oct 31, 2022 6:40am
Novel CAR-T for solid tumors targets proteins in cancer cells
Nov 3, 2021 12:00pm
Can a cancer drug combo for adults treat kids with neuroblastoma?
Nov 15, 2018 11:31am
Y-mAbs preps $92M IPO to push lead assets through regulatory filing
Aug 27, 2018 7:05am
Using Zika virus to treat neuroblastoma
Jul 25, 2018 2:00pm
